# budesonide

NDC: 0574-9855
Generic name: budesonide
Labeler / Manufacturer: Padagis US LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20180629

FDA application: NDA021324

## Active ingredients

- BUDESONIDE: 3 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0574-9855"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0574-9855
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3a18d5a7-04c5-4137-8155-70a8adc0a48b